原料介紹
Lymphaselect®萃取自黃香草木樨Melilotus officinalis。黃香草木樨自遠古以來就被用於治療炎症、潰瘍和腫脹,稍後到15至19世紀,許多中西醫用這種植物與類似用途,並用於消化、利尿、祛痰、眼睛發炎、痔瘡、靜脈炎、靜脈曲張、潰瘍,以及減輕各種原因引起的疼痛。Lymphaselect®從黃香草木樨乾花提取出來,其主要活性成分香豆素達到標準化17-20%。
原料功效
Lymphaselect®對於靜脈和毛細血管有保護作用,同時它也被報導有效治療與乳腺增生以及乳腺痛相關的局部循環問題.
Lymphaselect®具有以下功能:
可刺激淋巴管從而增加淋巴液流量,也作用在胸導管的淋巴流量
刺激巨噬細胞,提高巨噬細胞的吞噬和分解蛋白質的功能
抗發炎和抗水腫活性,改善病症如高嶺土誘導性關節炎、熱水腫、淋巴滯留性水腫,及高蛋白性水腫等
改善靜脈和淋巴循環,有效治療慢性靜脈功能不全、靜脈曲張、血栓性靜脈炎、痔瘡、下肢淋巴性水腫,以及乳腺痛相關的淋巴水腫等
促進血液循環,增加組織和器官的毛細血管血流,如心肌和橫紋肌,並且可以保護心肌缺血引起的組織損傷
臨床文獻
1158 名靜脈曲張、250 名血栓性靜脈炎患者30 天改善主要症狀,減輕潰瘍水腫疼痛 Klein L. Phlebopathy treatment with Melilotus extract. Pren. Med. Argent. 1967;54:1191-3.
25名靜脈功能不全的孕婦20天改善主觀症狀 Leng J.J., et al., Treatment of varicose veins during pregnancy and in the postpartum. Clinical experimentation of Esberiven. Bordeaux med. 1974;7:2755-6
50名痔瘡患者10-28天改善主觀症狀,減少肛門痔瘡、水腫 Mot J.C (1976). New therapeutic contribution in proctology: esberiven. Med. Chir. Dig. 1976; 5(7): 375-7.
30名慢性靜脈功能不全、靜脈曲張患者10-20天改善主觀症狀,減少水腫 Babilliot J (1977). Essay of Esberiven in Pathology of the Circulatory System of Return. Phlébologie 1977; 30 (2): 209-12.
385名慢性靜脈功能不全患者45天改善主觀症狀,減輕水腫潰瘍 Babilliot J (1980). Contribution to the treatment of venous insufficiency by Esberiven. Multicenter study on 385 cases. Gaz. méd. fr., 1980, 87 : 3242-6.
20名乳腺痛患者每月治療10天,2個月改善症狀,減輕乳房水腫 Giraud D. Trial of phlebo-lymphologic therapeutics in the treatment of mastodynia. Rev. Fr. Gynecol. Obstet. 1984; 79 (3): 229-32
55位慢性靜脈功能不全患者15天減輕水腫,改善主觀症狀 Stefanini L., et al., Pharmacologic treatment and/or balneotherapy of chronic venous insufficiency. Gazz. Med. Ital. - Arch. Sci. Med. 1996; 155: 179-85.
76位淋巴性水腫患者6-8個月改善主觀症狀,減輕水腫 Vettorello G. et al., Contribution of a combination of alpha and beta benzopyrones, flavonoids and natural terpenes in the treatment of lymphedema of the lower limbs at the 2d stage of the surgical classification. Minerva Cardioangiol. 1996; 44(9): 447-55.
50名乳腺痛患者2個月減輕乳房水腫,改善功能性症狀 Mazzocchi B., et al., Treatment of cyclic and non-cyclic mastalgia using Melilotus officinalis extracts, in a group of women submitted to breast examination. Gazz Med Ital – Arch Sci Med 1997; 156: 221-4
Lymphaselect®是米蘭公司Indena S.P.A.的註冊商標
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
美國食品藥物管理局並未對此文宣內容中提起的各項說明做出任何評估。本產品不具任何醫療、診斷、治療和預防疾病的效果。